- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.10. | FW Thorpe FY24 Pretax Profit Rises | ||
| 02.10. | Spero Therapeutics Reports Phase 1 Results Show Significant Lung Uptake Of SPR719 | ||
| 02.10. | Caesars To Offer $1 Bln Of Senior Notes, Stock Up Over 5% | ||
| 02.10. | Conagra Brands Trading Lower In Pre-market As Q1 Results Missed View | ||
| 02.10. | Vimeo Confirms Charlie Ungashick As Chief Marketing Officer | ||
| 02.10. | LPL Financial Terminates CEO Dan Arnold; Names Interim Replacement; Stock Down | ||
| 02.10. | RPM International Inc Q1 Profit Increases, Beats Estimates | ||
| 02.10. | Liquidia Amends License Agreement For L606 To Include Key Markets In Europe, Japan | ||
| 02.10. | Hansard Global Names Ollie Byrne CFO | ||
| 02.10. | Skanska Secures $80 Mln Supplemental Award For Data Hall Construction In Georgia, USA | ||
| 02.10. | Wynnstay Group Warns On Weak FY Results, Below Current Market View | ||
| 02.10. | Topps Tiles Q4 Group Sales Down 4.4%; Like-for-like Sales Down 8.2% | ||
| 02.10. | Wizz Air Traffic, Capacity Rise In September, Q2 | ||
| 02.10. | Commonwealth Bank Of Australia Announces Executive Leadership Team Changes | ||
| 02.10. | Opendoor Technologies Appoints Alphabet Executive Selim Freiha As CFO | ||
| 02.10. | Crescent Energy To Replace Perficient In S&P SmallCap 600 | ||
| 01.10. | Audi Of America Q3 Deliveries Fall By 21% | ||
| 01.10. | PTC Therapeutics Reports Filing Acceptance For Sepiapterin | ||
| 01.10. | Signet Jewelers Names Symancyk To Succeed Drosos As CEO | ||
| 01.10. | Spyre Therapeutics Appoints Sheldon Sloan As New Chief Medical Officer | ||
| 01.10. | Ollie's Bargain Outlet Wins Bid To Buy Seven Former Big Lots Store Leases | ||
| 01.10. | United Natural Foods Rises 7% In Pre-market On Upbeat Quarterly Results | ||
| 01.10. | Eros Resources, MAS Gold, Rockridge Resources To Combine | ||
| 01.10. | Ionis Pharma Says FDA Grants Fast Track Designation For Zilganersen To Treat Alexander Disease | ||
| 01.10. | CytoSorbents Announces DrugSorb-ATR De Novo Submission To FDA |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
